Skip to main content
Joshua Klopper, MD, Endocrinology, South San Francisco, CA

JoshuaPaulKlopperMD

Endocrinology South San Francisco, CA

Diabetes, Lipid Metabolism, Thyroid

Medical Director, Endocrinology - Veracyte, Inc.

Dr. Klopper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Klopper's full profile

Already have an account?

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2006
  • University of Colorado
    University of ColoradoResidency, Internal Medicine, 1999 - 2002
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1999

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2002 - 2025

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Introductory Hands-on Thyroid Ultrasound Workshop 
    ENDO 2019 - New Orleans, LA - 3/22/2019
  • Clinical Diabetes and Endocrinology in 2013 
    National Jewish Health, Snowmass, Colorado - 1/19/2013

Press Mentions

  • Veracyte Announces New Data Suggesting Afirma Testing Can Help Personalize Care for Patients with Thyroid Nodules
    Veracyte Announces New Data Suggesting Afirma Testing Can Help Personalize Care for Patients with Thyroid NodulesFebruary 1st, 2023
  • Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology
    Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of EndocrinologySeptember 1st, 2021
  • New Data Presented at the 2023 ATA Annual Meeting Demonstrate That Veracyte’s Afirma-Based Testing Can Uncover Key Molecular Hallmarks of Thyroid Cancer
    New Data Presented at the 2023 ATA Annual Meeting Demonstrate That Veracyte’s Afirma-Based Testing Can Uncover Key Molecular Hallmarks of Thyroid CancerOctober 10th, 2023
  • Join now to see all

Professional Memberships